Schedule 13G
CTMX Schedule 13G filing by Bank of America
Bank of America reported beneficial ownership of 15.1M shares, representing 7% of CYTOMX THERAPEUTICS INC in this filing.
FiledAug 3, 2026
Ownership dateJun 30, 2026
Reported shares15.1M
Reported ownership7%
Ownership details
Voting and dispositive power reported in the filing
These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.
Sole voting power
0
Shared voting power
15.1M
Sole dispositive power
0
Shared dispositive power
15.1M
Price context
Price dates alongside the ownership filing
Price data provides market context around the disclosure. It does not identify the filer’s actual transaction price.
Close near filing date$3.17as of Aug 3, 2026
Latest tracked price$3.33as of Aug 5, 2026
Source
Original filing and accession
Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.
- Reporting filer
- Bank of America
- CIK
- CIK0000070858
- Accession
- 0000070858-26-000395
- Form
- Schedule 13G
Read the filing in context